JUN 27, 2018 5:49 AM PDT

Efficacy of The 24 Hour Killing Flu Drug 'Xofluza' Examined

WRITTEN BY: Nouran Amin

Xofluza, the recent 24-hour killing flu drug that was developed by the Japanese pharmaceutical company Shionogi and approved for clinical use in Japan, is now being tested for its efficacy.

Researchers from EMBL Grenoble have examined in detail Xofluza’s mode of action; uncovering possible mechanisms by the possibility of viral resistance which was later published in Scientific Reports.

290,000 to 650,000 individuals die every year due to the flu and over 3 million severe illness cases worldwide are flu-associated. The flu is primarily an infectious disease caused by influenza viruses A and B. Although there is plenty of vaccines and anti-viral drugs to combat the flu, viral strain resistance to flu treatment continue to emerge and the need for a drug with optimum efficacy and novel mechanism of action is at an all-time high.

Xofluza, also known as baloxavir marboxil, is actually an anti-influenza drug approved for clinical use in the 1990s. When patients with the flu are administered Xofluza, their bodies will metabolize it into baloxavir acid. The acid then works to target a key viral enzyme known as influenza polymerase by inactivating its actions. This inactivation causes the influenza virus to be unable to replicate, ultimately halting the progression of an infection. The clinical studies on healthy patients by Shionogi provided evidence that one oral dose of Xofluza holds high efficacy in decreasing viral production and relieving symptoms.

Stephen Cusack, from EMBL Grenoble, examined specifically crystal structures of the drug bound to: 1.) a polymerase of the influenza virus and 2.) a mutant polymerase. The mutant polymerase leads to minor structural changes: one amino acid transforms into another using a single methyl group. "Still, this apparently minor change leads to reduced contact between the polymerase and the drug, weakening the drug's effect. However the virus pays a price for escaping the drug, since we found that the same mutation also lowers the activity of the polymerase, meaning that the mutant virus is less effective at replicating itself. It is therefore uncertain whether this Xofluza-resistant virus would ever spread,” says Cusack, "Only that way can we find out if resistance spreads and becomes a problem. Finding out could take several years, but at least we know what mutations to monitor. In the meantime, in our lab at EMBL Grenoble, we will keep working on influenza polymerase with the aim of supporting the development the next generation of influenza drugs."

Source: EurekaAlert

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 27, 2021
Drug Discovery & Development
Natural Remedy Better than Steroids For COVID-19 Smell Loss
APR 27, 2021
Natural Remedy Better than Steroids For COVID-19 Smell Loss
An international group of olfactory experts have recommended against the use of steroid treatments for loss of smell rel ...
MAY 02, 2021
Cannabis Sciences
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
MAY 02, 2021
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
Current research suggests that cannabidiol (CBD) oil may be effective in managing seizures in childhood-onset epilepsy. ...
MAY 12, 2021
Cardiology
Reversing the Heart Damage Seen in Marfan Syndrome
MAY 12, 2021
Reversing the Heart Damage Seen in Marfan Syndrome
Marfan syndrome is a genetic disorder that disrupts the connective tissues that anchor and link the body's organs, affec ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 24, 2021
Immunology
Gut-Healing Stem Cells to Treat HIV Infections
JUN 24, 2021
Gut-Healing Stem Cells to Treat HIV Infections
A new study has revealed how stem cells can be used to amplify immune responses to HIV, the virus that causes AIDS. The ...
JUL 12, 2021
Health & Medicine
Is Caffeine Good or Bad for Migraines?
JUL 12, 2021
Is Caffeine Good or Bad for Migraines?
The short answer is it's still not certain if caffeine helps or worsens migraines, but chronic consumption of caffei ...
Loading Comments...